nodes	percent_of_prediction	percent_of_DWPC	metapath
Bevantolol—ADRB1—coronary artery disease	0.229	0.543	CbGaD
Bevantolol—ADRB2—coronary artery disease	0.192	0.457	CbGaD
Bevantolol—Propranolol—Penbutolol—coronary artery disease	0.174	1	CrCrCtD
Bevantolol—ADRB2—Penbutolol—coronary artery disease	0.101	0.296	CbGbCtD
Bevantolol—ADRB1—Penbutolol—coronary artery disease	0.0995	0.291	CbGbCtD
Bevantolol—ADRB2—Timolol—coronary artery disease	0.0712	0.208	CbGbCtD
Bevantolol—ADRB1—Timolol—coronary artery disease	0.0701	0.205	CbGbCtD
Bevantolol—Papaverine—PDE3A—coronary artery disease	0.000672	0.132	CrCbGaD
Bevantolol—Carvedilol—NPPB—coronary artery disease	0.00045	0.0886	CrCbGaD
Bevantolol—Carvedilol—GJA1—coronary artery disease	0.00045	0.0886	CrCbGaD
Bevantolol—Carvedilol—SELE—coronary artery disease	0.000426	0.0839	CrCbGaD
Bevantolol—Papaverine—PDE4B—coronary artery disease	0.000412	0.0811	CrCbGaD
Bevantolol—Carvedilol—VCAM1—coronary artery disease	0.000407	0.0801	CrCbGaD
Bevantolol—Carvedilol—HIF1A—coronary artery disease	0.000341	0.0671	CrCbGaD
Bevantolol—Tamsulosin—HTR7—coronary artery disease	0.000209	0.0412	CrCbGaD
Bevantolol—Esmolol—ADRB1—coronary artery disease	0.000204	0.0401	CrCbGaD
Bevantolol—Bisoprolol—ADRB1—coronary artery disease	0.000173	0.0341	CrCbGaD
Bevantolol—Esmolol—ADRB2—coronary artery disease	0.000171	0.0337	CrCbGaD
Bevantolol—Bisoprolol—ADRB2—coronary artery disease	0.000146	0.0287	CrCbGaD
Bevantolol—Metoprolol—ADRB1—coronary artery disease	0.000138	0.0273	CrCbGaD
Bevantolol—Carvedilol—VEGFA—coronary artery disease	0.000137	0.027	CrCbGaD
Bevantolol—Metoprolol—ADRB2—coronary artery disease	0.000116	0.0229	CrCbGaD
Bevantolol—Propafenone—ADRB1—coronary artery disease	0.000102	0.0201	CrCbGaD
Bevantolol—Metoprolol—CYP2C19—coronary artery disease	0.0001	0.0197	CrCbGaD
Bevantolol—Carvedilol—ADRB1—coronary artery disease	9.19e-05	0.0181	CrCbGaD
Bevantolol—Carvedilol—ADRB2—coronary artery disease	7.73e-05	0.0152	CrCbGaD
Bevantolol—Verapamil—CYP2C19—coronary artery disease	7.67e-05	0.0151	CrCbGaD
Bevantolol—Propranolol—ADRB1—coronary artery disease	6.99e-05	0.0138	CrCbGaD
Bevantolol—Propranolol—ADRB2—coronary artery disease	5.88e-05	0.0116	CrCbGaD
Bevantolol—Propranolol—CYP2C19—coronary artery disease	5.06e-05	0.00996	CrCbGaD
Bevantolol—ADRA1A—Signaling by GPCR—PPP2CA—coronary artery disease	9.89e-06	0.00017	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCL3—coronary artery disease	9.84e-06	0.000169	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CXCL2—coronary artery disease	9.84e-06	0.000169	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SDC1—coronary artery disease	9.73e-06	0.000167	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—F2R—coronary artery disease	9.73e-06	0.000167	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PRKCD—coronary artery disease	9.71e-06	0.000167	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HTR7—coronary artery disease	9.69e-06	0.000166	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—FGB—coronary artery disease	9.53e-06	0.000163	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—HTR2A—coronary artery disease	9.5e-06	0.000163	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—C3—coronary artery disease	9.49e-06	0.000163	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—ITGAV—coronary artery disease	9.44e-06	0.000162	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—EDNRB—coronary artery disease	9.43e-06	0.000162	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—KNG1—coronary artery disease	9.41e-06	0.000162	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—POMC—coronary artery disease	9.38e-06	0.000161	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—CREB1—coronary artery disease	9.38e-06	0.000161	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—AGTR1—coronary artery disease	9.36e-06	0.000161	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—THBS1—coronary artery disease	9.29e-06	0.000159	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—ITGAV—coronary artery disease	9.23e-06	0.000158	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—KNG1—coronary artery disease	9.21e-06	0.000158	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PSMB5—coronary artery disease	9.2e-06	0.000158	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PSMA6—coronary artery disease	9.2e-06	0.000158	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—CCL2—coronary artery disease	9.18e-06	0.000158	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—POMC—coronary artery disease	9.18e-06	0.000157	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—CREB1—coronary artery disease	9.18e-06	0.000157	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—F2—coronary artery disease	9.18e-06	0.000157	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—AGTR1—coronary artery disease	9.15e-06	0.000157	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—IL6R—coronary artery disease	9.15e-06	0.000157	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CXCL10—coronary artery disease	9.14e-06	0.000157	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PLG—coronary artery disease	9.12e-06	0.000156	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—AGT—coronary artery disease	9.02e-06	0.000155	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—CCL2—coronary artery disease	8.98e-06	0.000154	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—IL6R—coronary artery disease	8.95e-06	0.000154	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CXCL10—coronary artery disease	8.94e-06	0.000153	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PLG—coronary artery disease	8.92e-06	0.000153	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—EDNRA—coronary artery disease	8.9e-06	0.000153	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—ADRB2—coronary artery disease	8.88e-06	0.000152	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CYBA—coronary artery disease	8.86e-06	0.000152	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—ADRB1—coronary artery disease	8.86e-06	0.000152	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—DUSP6—coronary artery disease	8.82e-06	0.000151	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PRKCE—coronary artery disease	8.76e-06	0.00015	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—JAK2—coronary artery disease	8.76e-06	0.00015	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—SOCS1—coronary artery disease	8.74e-06	0.00015	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—S100B—coronary artery disease	8.72e-06	0.00015	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PLAT—coronary artery disease	8.68e-06	0.000149	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—SOCS3—coronary artery disease	8.63e-06	0.000148	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PRKCE—coronary artery disease	8.57e-06	0.000147	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—JAK2—coronary artery disease	8.56e-06	0.000147	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—SOCS1—coronary artery disease	8.55e-06	0.000147	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—KITLG—coronary artery disease	8.53e-06	0.000146	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TGFBR2—coronary artery disease	8.53e-06	0.000146	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—S100B—coronary artery disease	8.53e-06	0.000146	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—SOCS3—coronary artery disease	8.45e-06	0.000145	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CXCL12—coronary artery disease	8.37e-06	0.000144	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—BDKRB2—coronary artery disease	8.37e-06	0.000144	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—POMC—coronary artery disease	8.36e-06	0.000143	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—KITLG—coronary artery disease	8.35e-06	0.000143	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TGFBR2—coronary artery disease	8.35e-06	0.000143	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MMP3—coronary artery disease	8.34e-06	0.000143	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—STAT5A—coronary artery disease	8.34e-06	0.000143	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—F2—coronary artery disease	8.33e-06	0.000143	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—IL6ST—coronary artery disease	8.3e-06	0.000142	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—JUNB—coronary artery disease	8.22e-06	0.000141	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PLCB1—coronary artery disease	8.19e-06	0.00014	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MMP3—coronary artery disease	8.16e-06	0.00014	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—STAT5A—coronary artery disease	8.16e-06	0.00014	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—APOB—coronary artery disease	8.06e-06	0.000138	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HTR7—coronary artery disease	8.02e-06	0.000138	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—CXCL8—coronary artery disease	7.99e-06	0.000137	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—JAK2—coronary artery disease	7.95e-06	0.000136	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—EDN1—coronary artery disease	7.93e-06	0.000136	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—APOB—coronary artery disease	7.88e-06	0.000135	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CCL5—coronary artery disease	7.87e-06	0.000135	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—CXCL8—coronary artery disease	7.82e-06	0.000134	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—JAK2—coronary artery disease	7.78e-06	0.000133	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—EDN1—coronary artery disease	7.76e-06	0.000133	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CSF2—coronary artery disease	7.75e-06	0.000133	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—FGF1—coronary artery disease	7.75e-06	0.000133	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CCL5—coronary artery disease	7.7e-06	0.000132	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—LPL—coronary artery disease	7.7e-06	0.000132	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—ITGAV—coronary artery disease	7.64e-06	0.000131	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MEF2C—coronary artery disease	7.63e-06	0.000131	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—RPS6KB1—coronary artery disease	7.63e-06	0.000131	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—KNG1—coronary artery disease	7.62e-06	0.000131	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—POMC—coronary artery disease	7.59e-06	0.00013	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CREB1—coronary artery disease	7.59e-06	0.00013	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CSF2—coronary artery disease	7.58e-06	0.00013	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—FGF1—coronary artery disease	7.58e-06	0.00013	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—AGTR1—coronary artery disease	7.57e-06	0.00013	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—LPL—coronary artery disease	7.53e-06	0.000129	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—RPS6KB1—coronary artery disease	7.46e-06	0.000128	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MEF2C—coronary artery disease	7.46e-06	0.000128	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—ITGB3—coronary artery disease	7.43e-06	0.000128	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CCL2—coronary artery disease	7.43e-06	0.000127	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—IL6R—coronary artery disease	7.4e-06	0.000127	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CXCL10—coronary artery disease	7.4e-06	0.000127	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PLG—coronary artery disease	7.38e-06	0.000127	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—ITGB3—coronary artery disease	7.27e-06	0.000125	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—CXCL8—coronary artery disease	7.26e-06	0.000125	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PPP2CA—coronary artery disease	7.22e-06	0.000124	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—ADRB2—coronary artery disease	7.18e-06	0.000123	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—CXCL8—coronary artery disease	7.1e-06	0.000122	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PRKCE—coronary artery disease	7.09e-06	0.000122	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PRKCD—coronary artery disease	7.09e-06	0.000122	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—JAK2—coronary artery disease	7.08e-06	0.000122	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SOCS1—coronary artery disease	7.07e-06	0.000121	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PPP2CA—coronary artery disease	7.06e-06	0.000121	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—S100B—coronary artery disease	7.05e-06	0.000121	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SOCS3—coronary artery disease	6.99e-06	0.00012	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HTR2A—coronary artery disease	6.94e-06	0.000119	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PRKCD—coronary artery disease	6.94e-06	0.000119	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—C3—coronary artery disease	6.93e-06	0.000119	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TGFBR2—coronary artery disease	6.9e-06	0.000118	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—KITLG—coronary artery disease	6.9e-06	0.000118	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HTR2A—coronary artery disease	6.79e-06	0.000116	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—C3—coronary artery disease	6.78e-06	0.000116	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MMP3—coronary artery disease	6.75e-06	0.000116	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—STAT5A—coronary artery disease	6.75e-06	0.000116	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HIF1A—coronary artery disease	6.61e-06	0.000113	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—AGT—coronary artery disease	6.58e-06	0.000113	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—APOB—coronary artery disease	6.52e-06	0.000112	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—CXCL8—coronary artery disease	6.47e-06	0.000111	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HIF1A—coronary artery disease	6.46e-06	0.000111	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—APOE—coronary artery disease	6.45e-06	0.000111	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—LEP—coronary artery disease	6.45e-06	0.000111	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—AGT—coronary artery disease	6.44e-06	0.000111	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—JAK2—coronary artery disease	6.43e-06	0.00011	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—EDN1—coronary artery disease	6.42e-06	0.00011	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—APOA1—coronary artery disease	6.38e-06	0.000109	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCL5—coronary artery disease	6.37e-06	0.000109	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—KDR—coronary artery disease	6.32e-06	0.000108	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—LEP—coronary artery disease	6.31e-06	0.000108	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—APOE—coronary artery disease	6.31e-06	0.000108	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MAPK14—coronary artery disease	6.28e-06	0.000108	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CSF2—coronary artery disease	6.27e-06	0.000108	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—FGF1—coronary artery disease	6.27e-06	0.000108	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—APOA1—coronary artery disease	6.24e-06	0.000107	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—LPL—coronary artery disease	6.23e-06	0.000107	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—KDR—coronary artery disease	6.18e-06	0.000106	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MEF2C—coronary artery disease	6.17e-06	0.000106	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—RPS6KB1—coronary artery disease	6.17e-06	0.000106	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—ESR1—coronary artery disease	6.16e-06	0.000106	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MAPK14—coronary artery disease	6.14e-06	0.000105	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—F2—coronary artery disease	6.08e-06	0.000104	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—FN1—coronary artery disease	6.08e-06	0.000104	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IL6ST—coronary artery disease	6.06e-06	0.000104	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—ESR1—coronary artery disease	6.02e-06	0.000103	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—ITGB3—coronary artery disease	6.01e-06	0.000103	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NFKBIA—coronary artery disease	6.01e-06	0.000103	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—F2—coronary artery disease	5.95e-06	0.000102	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—FN1—coronary artery disease	5.95e-06	0.000102	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IL6ST—coronary artery disease	5.93e-06	0.000102	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NFKBIA—coronary artery disease	5.88e-06	0.000101	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CXCL8—coronary artery disease	5.87e-06	0.000101	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PPP2CA—coronary artery disease	5.84e-06	0.0001	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—KIT—coronary artery disease	5.82e-06	9.99e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PRKCD—coronary artery disease	5.74e-06	9.84e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—KIT—coronary artery disease	5.69e-06	9.77e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HTR2A—coronary artery disease	5.61e-06	9.63e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—C3—coronary artery disease	5.61e-06	9.62e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—GSK3B—coronary artery disease	5.59e-06	9.59e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—POMC—coronary artery disease	5.54e-06	9.51e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CREB1—coronary artery disease	5.54e-06	9.51e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—GSK3B—coronary artery disease	5.46e-06	9.38e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CCL2—coronary artery disease	5.42e-06	9.3e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—POMC—coronary artery disease	5.42e-06	9.3e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CREB1—coronary artery disease	5.42e-06	9.3e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IL6R—coronary artery disease	5.41e-06	9.28e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HIF1A—coronary artery disease	5.35e-06	9.17e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IGF1—coronary artery disease	5.33e-06	9.15e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—AGT—coronary artery disease	5.33e-06	9.14e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—MAPK1—coronary artery disease	5.3e-06	9.1e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CCL2—coronary artery disease	5.3e-06	9.1e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IL6R—coronary artery disease	5.29e-06	9.07e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—APOE—coronary artery disease	5.22e-06	8.96e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—LEP—coronary artery disease	5.22e-06	8.96e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IGF1—coronary artery disease	5.21e-06	8.95e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—MAPK1—coronary artery disease	5.19e-06	8.91e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—APOA1—coronary artery disease	5.16e-06	8.85e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—KDR—coronary artery disease	5.11e-06	8.77e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MAPK14—coronary artery disease	5.08e-06	8.72e-05	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—PIK3CA—coronary artery disease	5.07e-06	8.7e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—SERPINE1—coronary artery disease	5.06e-06	8.69e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—ESR1—coronary artery disease	4.98e-06	8.55e-05	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—PIK3CA—coronary artery disease	4.96e-06	8.51e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—SERPINE1—coronary artery disease	4.95e-06	8.5e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—FN1—coronary artery disease	4.92e-06	8.45e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—F2—coronary artery disease	4.92e-06	8.45e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IL6ST—coronary artery disease	4.9e-06	8.41e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—FGF2—coronary artery disease	4.9e-06	8.41e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NFKBIA—coronary artery disease	4.86e-06	8.35e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NOS3—coronary artery disease	4.83e-06	8.29e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—FGF2—coronary artery disease	4.79e-06	8.23e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NOS3—coronary artery disease	4.73e-06	8.11e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—KIT—coronary artery disease	4.71e-06	8.08e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—JAK2—coronary artery disease	4.7e-06	8.06e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—PIK3CA—coronary artery disease	4.6e-06	7.9e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—JAK2—coronary artery disease	4.59e-06	7.88e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GSK3B—coronary artery disease	4.52e-06	7.76e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—PIK3CA—coronary artery disease	4.5e-06	7.73e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—POMC—coronary artery disease	4.48e-06	7.69e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CREB1—coronary artery disease	4.48e-06	7.69e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCL2—coronary artery disease	4.39e-06	7.53e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IL6R—coronary artery disease	4.37e-06	7.51e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IGF1—coronary artery disease	4.31e-06	7.4e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—MAPK1—coronary artery disease	4.29e-06	7.37e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CXCL8—coronary artery disease	4.29e-06	7.36e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CXCL8—coronary artery disease	4.19e-06	7.2e-05	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—AKT1—coronary artery disease	4.14e-06	7.11e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CASP3—coronary artery disease	4.1e-06	7.04e-05	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	4.1e-06	7.04e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	4.1e-06	7.03e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—IL6—coronary artery disease	4.08e-06	6.99e-05	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—AKT1—coronary artery disease	4.05e-06	6.95e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CASP3—coronary artery disease	4.01e-06	6.89e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CCND1—coronary artery disease	3.99e-06	6.85e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—IL6—coronary artery disease	3.99e-06	6.84e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	3.96e-06	6.8e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	3.91e-06	6.71e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CCND1—coronary artery disease	3.91e-06	6.7e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MMP9—coronary artery disease	3.88e-06	6.65e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	3.8e-06	6.52e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MMP9—coronary artery disease	3.79e-06	6.51e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	3.76e-06	6.45e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	3.72e-06	6.39e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—AKT1—coronary artery disease	3.68e-06	6.31e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	3.48e-06	5.97e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	3.47e-06	5.95e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—VEGFA—coronary artery disease	3.41e-06	5.84e-05	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	3.35e-06	5.75e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	3.32e-06	5.7e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	3.3e-06	5.66e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	3.23e-06	5.54e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	3.2e-06	5.48e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	3.14e-06	5.38e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	3.13e-06	5.38e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TGFB1—coronary artery disease	3.13e-06	5.36e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MAPK1—coronary artery disease	3.07e-06	5.26e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	3.04e-06	5.22e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	2.82e-06	4.83e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	2.72e-06	4.67e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PIK3CA—coronary artery disease	2.66e-06	4.56e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	2.59e-06	4.44e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	2.54e-06	4.35e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IL6—coronary artery disease	2.41e-06	4.13e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IL6—coronary artery disease	2.36e-06	4.04e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—AKT1—coronary artery disease	2.22e-06	3.81e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	2.2e-06	3.78e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—AKT1—coronary artery disease	2.17e-06	3.73e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IL6—coronary artery disease	1.95e-06	3.34e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	1.8e-06	3.08e-05	CbGpPWpGaD
